Pasithea Therapeutics Corp. Share Price
KTTAPasithea Therapeutics Corp. Stock Performance
Open $0.70 | Prev. Close $0.71 | Circuit Range N/A |
Day Range $0.70 - $0.70 | Year Range $0.67 - $3.85 | Volume 263 |
Average Traded $0.70 |
Pasithea Therapeutics Corp. Share Price Chart
About Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp., a clinical-stage biotechnology company, focuses on the discovery, research, and development of treatments for central nervous system (CNS) disorders, RASopathies, and cancers. Its lead product candidate is PAS-004, a next-generation macrocyclic mitogen-activated protein kinase, or MEK inhibitor to treat a range of RASopathies, including neurofibromatosis type 1 (NF1); MAPK pathway-driven tumors, such as BRAFv600 and BRAF fusion tumors; and ETS2 driven diseases, including inflammatory bowel disease (IBD), primary sclerosing cholangitis, and ankylosing spondylitis. The company's lead development candidate is PAS-003, to treat amyotrophic lateral sclerosis. It also intends to develop PAS-001, to treat schizophrenia. Pasithea Therapeutics Corp. was incorporated in 2020 and is headquartered in Miami Beach, Florida.
Pasithea Therapeutics Corp. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
12-Nov-25 | $0.70 | $0.70 | +0.00% |
12-Nov-25 | $0.70 | $0.70 | -0.85% |
10-Nov-25 | $0.72 | $0.71 | +6.29% |
07-Nov-25 | $0.68 | $0.67 | -7.22% |
06-Nov-25 | $0.76 | $0.72 | -2.31% |
05-Nov-25 | $0.74 | $0.74 | -0.41% |
04-Nov-25 | $0.70 | $0.74 | -8.87% |
FAQs on Pasithea Therapeutics Corp. Share Price
Can I buy Pasithea Therapeutics Corp. shares in India?
What is the share price of Pasithea Therapeutics Corp.?
What is the 5 year returns of Pasithea Therapeutics Corp.?
What are the high & low stock price of Pasithea Therapeutics Corp. today?
What is the 52-week high and low of Pasithea Therapeutics Corp. stock?